The suppression of brain cancer cells (U87MG) has been documented with gamma‐tocotrienol administered together with Jerantinine A, an indole alkaloid which is a potent anti‐proliferative agent that disrupted the G0/G1 interphase and microtubular polymerization, through Fas Ligand (FasL) and protein 53 (p53)‐stimulated apoptosis via the intrinsic mitochondrial pathway.72 This evidence concerns the gene FASLG and brain cancer.